B

(redirected from Soft tissue sarcoma)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.

B

abbreviation for BARON, judge of the COURT OF EXCHEQUER.
References in periodicals archive ?
The growth of the global soft tissue sarcoma market would depend on factors like various healthcare-related investments.
Among the studied population the most prevalent site of Extremity soft tissue sarcoma was in upper limb (55.5%).
These two case reports suggest a different but successful approach of the coverage after the wide excision of the soft tissue sarcoma of the hand.
Radiation is a known risk factor for soft tissue sarcomas. One population based, retrospective cohort study showed the standardized incidence ratio for angiosarcoma was 26.2(95% CI,16.5-41.4) in the radiation therapy group compared to 2.1(95% CI,1.0-4.4) in the groups not receiving radiation therapy.
A soft tissue sarcoma of the extensor mechanism poses a particularly demanding surgical situation.
Based on the available safety and efficacy data, the Independent Data Monitoring Committee recommended the continuation of the ongoing Phase II/III trial of NBTXR3 in soft tissue sarcoma.
Specifically, it was a malignant solitary fibrous tumour, a form of soft tissue sarcoma. Janice was 39 years old when she was diagnosed.
Localized management of soft tissue sarcoma metastasis: A review of a multidisciplinary approach.
At this time, it was announced that pazopanib would become clinically available in the near future for second-line chemotherapy against advanced soft tissue sarcoma. Hence, we decided to initially treat this patient by systemic chemotherapy with combination use of ifosfamide (10 g/[m.sup.2]/cycle) and doxorubicin (75 mg/[m.sup.2]/cycle) (IFM/DXR) and to switch to pazopanib once it became commercially available.
This case report describes the clinical, pathological, and immunohistochemical findings in a dog with a high-grade soft tissue sarcoma that occurred at a recent vaccination site and the clinical results of surgical resection followed by targeted therapy with toceranib.
(1) Diagnosis of a bone or soft tissue sarcoma (non-RMS soft tissue sarcomas and other sarcomas, e.g., clear cell adrenal and renal sarcomas, were not included)